To evaluate the role of BIM in this synergistic mechanism, we used Co-IP to determine the interaction of BIM with Bcl-2 and Bcl-xL in pevonedistat ± SEL treated ALL cells. Here, BCL2L11 is linked to acute lymphoblastic leukemia.